Reduced triglyceridemia and increased high density lipoprotein cholesterol levels after treatment with acipimox, anew inhibitor of lipolysis
- 1 February 1981
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 38 (3-4) , 267-271
- https://doi.org/10.1016/0021-9150(81)90042-3
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- The Analysis of the Two-Period Repeated Measurements Crossover Design with Application to Clinical TrialsBiometrics, 1977
- Measurement of squalene in human tissues and plasma: validation and applicationJournal of Lipid Research, 1976
- Results of the coronary drug project — An interpretationAtherosclerosis, 1975
- Dietary Management of Hyperlipoproteinemia1Journal of the American Dietetic Association, 1971
- Improved Accuracy in Automated Fluorometric Determination of Plasma TriglyceridesClinical Chemistry, 1970
- A comparison of heritable abnormal lipoprotein patterns as defined by two different techniquesJournal of Clinical Investigation, 1968
- Induction of adipose tissue lipoprotein lipase by nicotinic acidBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1968
- The Two-Period Change-Over Design and Its Use in Clinical TrialsPublished by JSTOR ,1965